|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/50 | (2006.01) |
| A61K 9/51 | (2006.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 31/12 | (2006.01) | ||
| A61K 31/4965 | (2006.01) | ||
| A61K 31/5575 | (2006.01) | ||
| A61K 33/00 | (2006.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Patento numeris | 2893922 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15150623.5 |
| Europos patento paraiškos padavimo data | 2015-01-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-07-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201400412 | 2014-01-10 | GB |
| (72) |
Yacoub, Magdi , GB
El Sherbiny, Ibrahim , EG
|
| (73) |
Heart Biotech Pharma Limited ,
17 North Drive, Littleton, Winchester SO22 6QA,
GB
|
| (54) | Pharmaceutical formulations for the treatment of pulmonary arterial hypertension |
| Pharmaceutical formulations for the treatment of pulmonary arterial hypertension |